MolNFT v1 · #132321 · protein
T. brucei fpps in complex with cid 47256035
5QTJ · Farnesyl pyrophosphate synthase: “T. brucei fpps in complex with cid 47256035”. X-ray diffraction, 3 ligands (PJS, NA, PO4), 2 pockets (best druggability 0.71). MolNFT v1 #132321 on GenesisL1: 3D structure, binding sites and pockets…
- PDB
- 5QTJ
- Type
- protein
- Length
- 330 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Farnesyl pyrophosphate synthase
- UniProt
- Q86C09
- Ligands
- PJS, NA, PO4
- Pockets
- 2 · best druggability 0.71
Structure
x-ray diffraction · 1 distinct chain · 77% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Farnesyl pyrophosphate synthase | protein | 330 | 77% helix, 0% strand | Q86C09 |
Ligands and binding sites
- PJS · N-[(2-chloro-6-fluorophenyl)methyl]-N,2-dimethylpyrimidine-4-carboxamide · ligand · chains A
- NA · Sodium ion · metal · chains A
- PO4 · Phosphate ion · ion · 2 copies · chains A
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 686 | 0.71 | 0.78 | 60 | PJS, NA, PO4, GOL |
| 2 | 50 | 0.32 | 0.77 | 10 | empty |
Compared structures
- 5QTJ · T. brucei FPPS in complex with CID 47256035 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q86C09
- Elsewhere: RCSB PDB 5QTJ · PDBe 5QTJ · UniProt Q86C09
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.